Michael J. Wartell filed an initial statement of beneficial ownership (Form 3) with the SEC on November 6, 2026, disclosing his status as a newly appointed director of Fractyl Health, Inc. as of November 2, 2026.
Delta Air Lines President Peter W. Carter filed a Form 4 on November 6, 2026, disclosing the sale of 44,950 shares of Delta Air Lines common stock on November 4, 2026.
Kontoor Brands, Inc. filed a Form 8-K on November 6, 2026, disclosing the completed sale of its wholly-owned subsidiary The H.D. Lee Company, Inc. to ABG-Storm LLC, an affiliate of Authentic Brands Group, on November 2, 2026.
Alclear Investments, LLC filed a Form 4 with the SEC on November 6, 2026, disclosing the sale of 176,096 shares of Clear Secure, Inc. Class A Common Stock on November 4, 2026, executed pursuant to a Rule 10b5-1 trading plan.
Caryn Seidman Becker, Chief Executive Officer and 10% owner of Clear Secure, Inc. (NYSE:YOU), filed a Form 4 on November 6, 2026, disclosing the sale of 176,096 shares of Class A Common Stock on November 4, 2026, along with related unit exchanges completed on …
Daniel Patrick O'Day, Chairman and CEO of Gilead Sciences, Inc., filed a Form 4 on November 6, 2026, disclosing the exercise of non-qualified stock options and sale of common stock on November 4 and November 5, 2026, pursuant to a Rule 10b5-1 trading plan.
Shannon T Kelley, General Counsel of Madrigal Pharmaceuticals, Inc., filed a Form 4 on November 6, 2026, disclosing the sale of 1,077 shares of common stock at $400 per share under a pre-established Rule 10b5-1 trading plan.
Jazz Pharmaceuticals Public Limited Company director Bruce Cozadd filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 68,808 common shares on NASDAQ following a stock option exercise.
Director William F. Galtney Jr. filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 7,500 shares of Everest Group, Ltd. common stock on the New York Stock Exchange.
David Zaslav, a director of Grupo Televisa, S.A.B., filed a Form 144 notice on November 6, 2026, proposing the sale of 46,600 Series "A" Shares of Grupo Televisa through J.P. Morgan Securities LLC on the New York Stock Exchange.